Hepatitis Vaccines

Combined Hepatitis A and B Vaccine is Cheaper in Long Run

Published in Vaccine Weekly, March 15th, 2000

A combined hepatitis A and B vaccination strategy, while initially more expensive, can actually save public health dollars in the long run according to a review of such strategies.

The report was one of several dealing with a combined hepatitis A and B vaccine published in the February 2000 issue of Vaccine.

A recent study in Germany analyzed the epidemiological and economic impact of combined hepatitis A and hepatitis B vaccination of all one- to 15-year-olds or of all 11- to 15-year-olds projected over three periods of 10 years compared with a strategy of non-vaccination.

"Vaccination of all one- to 15-year-olds will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-03-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry